Transforaminal lumbar interbody fusion surgery
ProcedureFortilink-TC Ti
NCT Number: NCT07834931
This study is setup to be able to gather information on the safety and performance of the Fortilink-TC Ti cage of Paradigm Spine GmbH, up to one year after the surgery. The device is intended to be used in intervertebral fusion surgery. Around 50 participants will participate in this study in 2 hospitals. The Fortilink-TC Ti cage is meant to be placed in the lower back, to treat degenerative disc disease with up to grade I spondylolisthesis. The study will involve data gathering based on routine care. The study will only entail collection of data (medical history prior to the surgery, data from the surgery and data in the follow up after one year). Fortilink-TC Ti cages are not new, but have been on the market since 2020. The clinical study is performed to actively gather data on the use of this product in the intended group of patients, to monitor its safety and performance. The treatment and follow-up provided in this study does not differ from the standard of care; meaning that participants in the study will receive the same treatment and follow the same follow-up visits and assessments as patients undergoing the same procedure outside of the study.
Interested in participating?
Request InfoAll sexes
Observational
Hospital Vithas de la Milagrosa, Madrid, Spain
This study is setup to be able to gather information on the safety and performance of the Fortilink-TC Ti cage of Paradigm Spine GmbH, up to one year after the surgery. The device is intended to be used in intervertebral fusion surgery. Around 50 participants will participate in this study in 2 hospitals. The Fortilink-TC Ti cage is meant to be placed in the lower back, to treat degenerative disc disease with up to grade I spondylolisthesis. The study will involve data gathering based on routine care. The study will only entail collection of data (medical history prior to the surgery, data from the surgery and data in the follow up after one year). Fortilink-TC Ti cages are not new, but have been on the market since 2020. The clinical study is performed to actively gather data on the use of this product in the intended group of patients, to monitor its safety and performance. The treatment and follow-up provided in this study does not differ from the standard of care; meaning that participants in the study will receive the same treatment and follow the same follow-up visits and assessments as patients undergoing the same procedure outside of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fortilink-TC Ti
Time frame: Improvement in ODI score at 12 months over baseline
Change between baseline and 12 months follow-up
Time frame: Baseline to 12 months post-surgery
Time frame: Up to 12 months post-surgery
Time frame: During follow-up through 12 months post-surgery
Imaging confirmed complications, such as subsidence, implant migration, or implant failure/breakage, identified during routine follow-up
Time frame: During follow-up through 12 months post-surgery
Fusion status based on imaging performed during routine follow-up
Interested in participating?
Request InfoBAAT Medical Products B.V.
Industry
Post-market Clinical Study of the Fortilink-TC Ti
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07834736
Bone Diseases, Degenerative Disc Disease Lumbar
Madrid, Spain
View Trial DetailsNCT03928041
Bone Diseases, Degenerative Disc Disease Lumbar
Charlotte, North Carolina, United States
View Trial DetailsNCT06709391
Back Pain, Bone Diseases
Gothenburg, Sweden
View Trial DetailsNCT07386548
Back Pain, Bone Diseases
Manhattan, New York, United States
View Trial Details